MU Stock News Micron Technology (MU) 32.13 07/30/2014 00:41:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Micron Technology (MU) 32.13 $MU

Most active Nasdaq-traded stocks
AP - Tue Jul 29, 5:02PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:

4 Hot Stocks to Trade (or Not)
at The Street - Tue Jul 29, 8:07AM CDT
Here's how to trade some of the most active stocks on the market today.

Inside IBD Big Cap 20: Facebook, Apple Thrive
at Investor's Business Daily - Mon Jul 28, 5:37PM CDT
A birds-eye view of the weekly Big Cap 20 shows no major change in the overall industry landscape. Oil stocks and the somewhat related members of the transportation sector still maintain a vise-like grip of the list. However, thanks in large part to...

Uptrend Call Working As Micron Technology Stock Rises 28.0% (MU)
Comtex SmarTrend(R) - Mon Jul 28, 5:13PM CDT
SmarTrend identified an Uptrend for Micron Technology (NASDAQ:MU) on April 21st, 2014 at $24.97. In approximately 3 months, Micron Technology has returned 28.05% as of today's recent price of $31.98.

Micron Technology Set to Possibly Rebound After Yesterday's Selloff of 4.31%
Comtex SmarTrend(R) - Mon Jul 28, 3:41PM CDT
Micron Technology (NASDAQ:MU) traded in a range yesterday that spanned from a low of $31.91 to a high of $33.46. Yesterday, the shares fell 4.3%, which took the trading range below the 3-day low of $33.23 on volume of 34.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Micron Technology Falls 4.31% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Jul 28, 3:40PM CDT
Micron Technology (NASDAQ:MU) traded in a range yesterday that spanned from a low of $31.91 to a high of $33.46. Yesterday, the shares fell 4.3%, which took the trading range below the 3-day low of $33.23 on volume of 34.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Semiconductor ETFs on Roller Coaster Ride after Earnings Beat - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Mon Jul 28, 12:00PM CDT
Though these products were on a wild ride last week despite earnings beat, these could make for a compelling buying opportunity for investors given bright industry outlook.

Main Indexes Stage Comeback; Chipotle Stays Hot
at Investor's Business Daily - Mon Jul 28, 11:01AM CDT
Stocks were again under water but had trimmed some of their earlier losses near Monday's halftime. The Nasdaq was off by 0.2% and the S&P 500 slipped 0.1%. They were off by as much as 0.8% and 0.6% respectively at Monday's lows. Meanwhile, the Dow...

Why Micron Technology (MU) Stock Is Still a 'Buy'
at The Street - Mon Jul 28, 9:44AM CDT
TheStreet Ratings team reiterated its 'buy' rating for Micron Technology (MU).

Micron Technology to Host Aug. 6 Hong Kong Analyst Conference
GlobeNewswire - Mon Jul 28, 7:06AM CDT
Micron Technology, Inc. (Nasdaq:MU) will host an analyst conference in Hong Kong on Wednesday, Aug. 6, 2014. Mark Durcan, Micron's Chief Executive Officer, and other executive officers will present Micron's strategy and provide an update on current market conditions.

Watch for Shares of Micron Technology (MU) to Approach Support at $33.28
Comtex SmarTrend(R) - Fri Jul 25, 10:14AM CDT
Shares of Micron Technology (NASDAQ:MU) opened today below their pivot of $33.93 and have already reached the first level of support at $33.58. Should the shares continue to fall, the support pivots of $33.28 and $32.63 will be of interest.

Critical Alerts For Micron, McDonald's, Boeing, Medtronic, and T-Mobile US Released By InvestorsObserver
PR Newswire - Fri Jul 25, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for MU, MCD, BA, MDT, and TMUS.

Why SanDisk Corporation Shares Could Drop Even Further
Srdjan Bejakovic, The Motley Fool - Motley Fool - Thu Jul 24, 10:00AM CDT
SanDisk's   impressive and long-running share-price growth came to a screeching halt last week after the company announced second-quarter earnings. Selling price erosion, decreasing gross margin, and guidance that failed to meet analysts'...

Micron Technology Appoints Stephen Pawlowski as Vice President of Advanced Computing Solutions
GlobeNewswire - Thu Jul 24, 7:41AM CDT
Micron Technology, Inc. (Nasdaq:MU), today announced that Stephen Pawlowski has been named as vice president of Advanced Computing Solutions.

Micron Prices $1.15 Billion Offering of 5.50% Senior Notes
Thomson Reuters ONE - Wed Jul 23, 10:35PM CDT
BOISE, Idaho, July 24, 2014 (GLOBE NEWSWIRE) -- Micron Technology, Inc., (Nasdaq:MU) today announced the pricing of an offering of $1.15 billion aggregate principal amount of its 5.50% senior notes due 2025 (the "Notes". The Notes are being offered to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act", and outside the United States to non-U.S. persons pursuant to Regulation S under the Securities Act. The sale of the Notes is expected to close on July 28, 2014, subject to the satisfaction of customary closing conditions. Interest on the Notes will accrue at a rate of 5.50% per year, and will be payable in cash semi-annually in arrears, beginning on February 1, 2015.

Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom
at The Street - Wed Jul 23, 7:05PM CDT
Should investors settle for average results? Absolutely not, Cramer says.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 316

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 0

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 291

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 406

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Rise of the Aluminum Alloy Wheel Market

Updated Category News Views 91

Overview of the Aluminum Alloy Wheel Market The Aluminum Alloy Wheel market has experienced notable growth and shows a bright future ahead. With ongoing innovations from manufacturers and shifting consumer preferences, the market is projected to reach approximately USD 33.2 billion by 2033. This growth translates to an estimated compound annual growth rate (CAGR) of 7.2%...

Continue Reading
Prominent Speakers Set to Illuminate Fortune Global Forum

Updated Category News Views 191

Global Icons to Speak at Fortune Global Forum 2024 Excitement is building around the upcoming Fortune Global Forum, where some of the most influential leaders in business and policy will converge. This event, set for November 11-12, promises rich dialogues on pressing global issues. Among the key figures attending are Tom Brady, the renowned seven-time world champion, and...

Continue Reading
IGT Unveils Diverse Wheel of Fortune Products at G2E 2024

Updated Category News Views 187

IGT Launches Exciting New Offerings for Wheel of Fortune International Game Technology PLC, better known as IGT, is famous for creating vibrant and engaging gaming experiences. At the upcoming Global Gaming Expo (G2E), IGT will proudly showcase a range of new products dedicated to the beloved Wheel of Fortune brand. Attendees can look forward to an exciting lineup that...

Continue Reading
Market Dynamics and Short Selling Insights About Disney

Updated Category News Views 132

Understanding Short Selling for Walt Disney Walt Disney's short percent of float has experienced a notable increase, now standing at 8.04% from the latest report. Presently, there are 21.70 million shares sold short, which accounts for 1.21% of all available regular shares. With the current trading volume, it is estimated that it would take around 3.12 days on average for...

Continue Reading
Heritage Commerce Corp Announces Quarterly Dividend of $0.13

Updated Category News Views 155

Heritage Commerce Corp Declares Dividend to Shareholders Heritage Commerce Corp (NASDAQ: HTBK), a respected bank holding company in the financial sector, recently shared exciting news with its stakeholders. The Board of Directors has approved a cash dividend of $0.13 per share for all common stock holders. This positive announcement reflects the company's commitment to...

Continue Reading